Expression of p53, Bax and Bcl-2 proteins in hepatocytes in non-alcoholic fatty liver disease
about
Targeting inflammation in diabetes: Newer therapeutic optionsThe role of the p53 tumor suppressor in metabolism and diabetesNonalcoholic fatty liver disease and aging: epidemiology to management.Depending on the stage of hepatosteatosis, p53 causes apoptosis primarily through either DRAM-induced autophagy or BAX.Recent Advances in Understanding of NASH: MicroRNAs as Both Biochemical Markers and Players.Integrative genomic signatures of hepatocellular carcinoma derived from nonalcoholic Fatty liver disease.Serum Bcl-2 concentrations in overweight-obese subjects with nonalcoholic fatty liver diseaseEffect of miR-146 targeted HDMCP up-regulation in the pathogenesis of nonalcoholic steatohepatitisDecrease of survivin, p53 and Bcl-2 expression in chemorefractory colorectal liver metastases may be predictive of radiosensivity radiosensivity after radioembolization with yttrium-90 resin microspheresRutin Attenuates Hepatotoxicity in High-Cholesterol-Diet-Fed Rats.Glycyrrhizic acid attenuates CCl₄-induced hepatocyte apoptosis in rats via a p53-mediated pathwayThe p53 Codon 72 Polymorphism Modifies the Cellular Response to Inflammatory Challenge in the LiverApoptosis and cytokines in non-alcoholic steatohepatitis.Is p53 Involved in Tissue-Specific Insulin Resistance Formation?Fatty acids and the endoplasmic reticulum in nonalcoholic fatty liver diseaseSystematic review of performance of non-invasive biomarkers in the evaluation of non-alcoholic fatty liver disease.Calcium signaling in the liverp53 in liver pathologies-taking the good with the bad.Deferoxamine ameliorates hepatosteatosis via several mechanisms in ob/ob mice.MicroRNA-21 is a potential link between non-alcoholic fatty liver disease and hepatocellular carcinoma via modulation of the HBP1-p53-Srebp1c pathway.Mutant p53 in concert with an interleukin-27 receptor alpha deficiency causes spontaneous liver inflammation, fibrosis, and steatosis in miceCore domain mutant Y220C of p53 protein has a key role in copper homeostasis in case of free fatty acids overload.Inhibition of p53 attenuates steatosis and liver injury in a mouse model of non-alcoholic fatty liver disease.Increases in p53 expression induce CTGF synthesis by mouse and human hepatocytes and result in liver fibrosis in mice.Green tea extract attenuates CCl4-induced hepatic injury in male hamsters via inhibition of lipid peroxidation and p53-mediated apoptosis.From bed to bench: which attitude towards the laboratory liver tests should health care practitioners strike?Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expression.Non-esterified fatty acids activate the ROS-p38-p53/Nrf2 signaling pathway to induce bovine hepatocyte apoptosis in vitro.Differential effects of reticulophagy and mitophagy on nonalcoholic fatty liver disease.Non-Alcoholic Fatty Liver Disease.p53 as a Dichotomous Regulator of Liver Disease: The Dose Makes the Medicine.Obeticholic acid protects against hepatocyte death and liver fibrosis in a murine model of nonalcoholic steatohepatitis.
P2860
Q26852726-216435EE-9BF9-4229-B419-510EF75E443BQ28079903-7CD50FAD-C42B-47A5-9E34-B913839D1DBEQ34366861-1878318E-3992-4331-B753-B57F5F65E35BQ34819164-B1A7526B-E5B0-48E1-B1EE-CDC40C7364ADQ34821020-3FCBD4A7-54CE-4B34-B092-CD2BAB9BD2C7Q35628824-DA10F101-1E76-4749-85F4-8AA777C0914DQ35638789-0FB47969-1769-4FD3-AAD4-44753945C31BQ36323805-D16D7CEE-15EA-46E8-B658-8270D1059BDFQ36697911-2DF17E88-6EF6-4070-BE78-0698B02044AFQ36889773-73C4D265-B365-4B7C-BFF5-055AB191E5A9Q36975008-5F925055-AD9F-4FF5-8785-D4DC8F04440AQ37120247-4E48A8D8-DEB2-489E-9E33-A595F77E4E73Q37396965-FD522254-264D-4F66-8665-88B6E9976F85Q37615064-8E14F814-1E5D-4AE2-81E4-7382DF21DE39Q37844020-06F74DF2-9F4E-4798-99F2-E8643C9BC356Q37850490-6384B976-4ED8-4747-9BD2-011DB95F9DBDQ38110517-3BFC2F9A-C609-49E9-A466-DE27FF1008D2Q38268953-4F7EB743-EA7B-4426-8DE3-79FEA7E3C116Q38291587-AE62AFE5-F361-43BC-83E7-4A8526B2C5CBQ38297030-20500AD1-3137-4C3E-B463-74D35C43D3B3Q38603775-73A2FB0C-DCEA-46A3-A919-E4B1D85CA3F2Q38830190-D0D60F36-ACDC-433D-90B3-2707070B2548Q39232535-F2B2688B-A8F9-4BD2-836B-E93AC65F00DEQ39508688-1E076879-FB8C-4F4A-AF95-5055D2996CADQ41680021-B932CBAA-60AF-4F29-BFA1-CF64E496FEA5Q42550368-5B2360E8-DD7F-49DC-8C03-A760F9CF126CQ46117666-9E142A58-3B8D-4FE9-93C0-4832D2228EA4Q46910085-C19D3EEF-DF2D-4961-8EBC-D070E9F457B8Q48171433-7617B823-62FC-46F6-A60B-AD87469680F5Q50957769-0ED4FD07-BAC2-4A46-B344-FCCD2ED5C3CAQ51761242-A10623BA-EF45-4CD5-B80C-897C0FD8064FQ55278681-E281C8CB-F6CD-4C82-A0CB-7E737737EE9D
P2860
Expression of p53, Bax and Bcl-2 proteins in hepatocytes in non-alcoholic fatty liver disease
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Expression of p53, Bax and Bcl ...... -alcoholic fatty liver disease
@ast
Expression of p53, Bax and Bcl ...... -alcoholic fatty liver disease
@en
type
label
Expression of p53, Bax and Bcl ...... -alcoholic fatty liver disease
@ast
Expression of p53, Bax and Bcl ...... -alcoholic fatty liver disease
@en
prefLabel
Expression of p53, Bax and Bcl ...... -alcoholic fatty liver disease
@ast
Expression of p53, Bax and Bcl ...... -alcoholic fatty liver disease
@en
P2093
P2860
P356
P1476
Expression of p53, Bax and Bcl ...... -alcoholic fatty liver disease
@en
P2093
Anatol Panasiuk
Bozena Panasiuk
Danuta Prokopowicz
Janusz Dzieciol
P2860
P304
P356
10.3748/WJG.V12.I38.6198
P407
P577
2006-10-01T00:00:00Z